000 01471 a2200421 4500
005 20250513150254.0
264 0 _c19981112
008 199811s 0 0 eng d
022 _a0268-1161
024 7 _a10.1093/humrep/13.6.1660
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFelberbaum, R E
245 0 0 _aTreatment of uterine fibroids with a slow-release formulation of the gonadotrophin releasing hormone antagonist Cetrorelix.
_h[electronic resource]
260 _bHuman reproduction (Oxford, England)
_cJun 1998
300 _a1660-8 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
650 0 4 _aAdult
650 0 4 _aChemistry, Pharmaceutical
650 0 4 _aFemale
650 0 4 _aGonadotropin-Releasing Hormone
_xadministration & dosage
650 0 4 _aHormone Antagonists
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aLeiomyoma
_xdrug therapy
650 0 4 _aMiddle Aged
650 0 4 _aTreatment Outcome
650 0 4 _aUterine Neoplasms
_xdrug therapy
700 1 _aGermer, U
700 1 _aLudwig, M
700 1 _aRiethmüller-Winzen, H
700 1 _aHeise, S
700 1 _aButtge, I
700 1 _aBauer, O
700 1 _aReissmann, T
700 1 _aEngel, J
700 1 _aDiedrich, K
773 0 _tHuman reproduction (Oxford, England)
_gvol. 13
_gno. 6
_gp. 1660-8
856 4 0 _uhttps://doi.org/10.1093/humrep/13.6.1660
_zAvailable from publisher's website
999 _c9654097
_d9654097